Stockreport

IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease

IGC Pharma, Inc.  (IGC) 
NASDAQ:AMEX Investor Relations: igcinc.us/investor-center/overview
PDF - Mouse Studies Demonstrate Significant Reduction in Amyloid Plaque: 78% in Cortex and 85% in Hippocampus - POTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. (NYSE Amer [Read more]